Transcend Capital Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,617
Closed -$286K 758
2025
Q4
$286K Sell
3,617
-1,209
-25% -$95.7K 0.02% 535
2025
Q3
$397K Buy
4,826
+529
+12% +$41.6K 0.03% 436
2025
Q2
$346K Buy
4,297
+1,092
+34% +$84.3K 0.03% 419
2025
Q1
$257K Buy
3,205
+635
+25% +$52.8K 0.02% 508
2024
Q4
$210K Sell
2,570
-185
-7% -$15.4K 0.02% 529
2024
Q3
$227K Buy
+2,755
New +$206K 0.02% 548
2024
Q2
Sell
-3,168
Closed -$235K 611
2024
Q1
$235K Buy
+3,168
New +$221K 0.02% 470
2022
Q3
Sell
-3,812
Closed -$239K 509
2022
Q2
$239K Sell
3,812
-1,339
-26% -$88.6K 0.02% 419
2022
Q1
$362K Buy
5,151
+232
+5% +$15.7K 0.03% 370
2021
Q4
$307K Buy
4,919
+134
+3% +$8.41K 0.03% 384
2021
Q3
$313K Buy
+4,785
New +$288K 0.03% 369
2021
Q2
Sell
-4,652
Closed -$282K 376
2021
Q1
$282K Sell
4,652
-43
-0.9% -$2.37K 0.03% 320
2020
Q4
$220K Buy
+4,695
New +$203K 0.03% 340

Other funds holding MET

Transcend Capital Advisors's MET Position: Q1 2026 in Review

Transcend Capital Advisors sold out of MetLife (MET) in Q1 2026, closing a stake of 3,617 shares — an estimated $286K sold.

Transcend Capital Advisors first reported a position in MET in Q4 2020 and held it in 13 quarters. The position peaked at $397K in Q3 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Transcend Capital Advisors reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
  • Transcend Capital Advisors sold 3,617 MetLife shares in Q1 2026, an estimated $286K.
  • Transcend Capital Advisors first reported a position in MetLife in Q4 2020 and held it in 13 quarters.
  • Transcend Capital Advisors's MetLife position peaked at $397K in Q3 2025.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Transcend Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.